Criam: Funding, Investors & Team (Sep 2026)
Criam is a Medtech company focused on blood type and disease detection. CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused on the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable, and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as a platform approach, we will be able to monitor, control and contain diseases worldwide.
Criam has raised $1.1M across 1 funding round on record, the most recent a Grant of $1.1M announced in Nov 2021.
That round is below the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Criam Company Profile and Key Stats
Latest funding round on record: Nov 2021.
Criam Funding Rounds
Criam Founders and Leadership Team
Contact details for the Criam team: 1 of 1 has an email address on file.
Start 14-day free trial →Criam Funding Compared to Other Biotechnology Startups
Criam's latest round of $1.1M is below the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Criam in Biotechnology and Braga
Companies Similar to Criam
We are dedicated to harness the power of nature, science and cellular agriculture technology to cultivate…
Noveome Biotherapeutics, Inc. is an advanced biopharmaceutical company that focuses on groundbreaking…
MAASH is a biotech mycoprotein producing company that supply a nutritious and health feed and food protein…
XiltriX North America is an information technology company that specializes in monitoring, predictive…
Adaptyv Biosystems developing a protein engineering platform using cell-free synthetic biology and…
Novir is an emerging diagnostic biotechnology company with an unmatched team of professionals and trusted…
Pixelgen Technologies, established in Sweden in 2020, focuses on the advancement of biomedical research and…
Computomics applies AI to bioinformatics data to enable rapid understanding of genomics and drive advanced…
Abcuro’s mission is to develop a new class of immune-modulatory bio-therapeutics for treating both…
Georgiamune Inc. is a privately-owned biotechnology company that specializes in advanced immunotherapy…
Bridge to Life was founded with the mission of improving organ transplants by licensing and developing new…
Criam Funding FAQs
What does Criam do?
Criam is a Medtech company focused on blood type and disease detection. CRIAM stands for Chemical Reaction and Image Analysis for Mobility. We are a Medtech startup born in January 2016 focused on the Point-of-Care diagnostic segment. Our mission is to provide fast, affordable, and in-situ blood test analysis to empower people with instant information about their well-being and health conditions. With our device as a platform approach, we will be able to monitor, control and contain diseases worldwide.
How much funding has Criam raised?
Criam has raised $1.1M across 1 round on record. The most recent is a Grant of $1.1M announced in Nov 2021.
When did Criam last raise funding?
Criam's most recent funding round on record is a Grant of $1.1M, announced in Nov 2021.
Who is the CEO of Criam?
Vitor Crespo is listed as CEO at Criam.
Where is Criam headquartered?
Criam is based in Braga, Portugal.
How many employees does Criam have?
Criam is in the 1-10 employee band.
How does Criam's funding compare to other Biotechnology startups?
Criam's latest round of $1.1M is below the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's Criam Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Criam is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.